Payment overview · 2025
General Payments
$185.44
11 reported records · 6 companies
Healthcare provider profile · identity verified
William Shane Lee, MD
Allopathic & Osteopathic Physicians|Family Medicine · MARION, AL · NPI 1568550721
Verified facts
What the public records show
CMS Open Payments records show William Shane Lee, MD received $185.44 in general payments during 2025 across 11 reported records.
Teva Pharmaceuticals USA, Inc. accounted for 25.5% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 6 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Austedo Xr, Ozempic, Rexulti.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 51 claims for Ozempic by this doctor in 2024.
Otsuka America Pharmaceutical, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ABILIFY MAINTENA as an associated drug or biological on 27924 records involving 10497 distinct recipient NPIs. Public Medicare Part D data also shows 11 claims for Abilify Maintena by this doctor in 2024.
Otsuka America Pharmaceutical, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported REXULTI as an associated drug or biological on 160756 records involving 46288 distinct recipient NPIs. Public Medicare Part D data also shows 31 claims for Rexulti by this doctor in 2024.
Teva Pharmaceuticals USA, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported AUSTEDO XR as an associated drug or biological on 86263 records involving 23643 distinct recipient NPIs. Public Medicare Part D data also shows 15 claims for Austedo Xr by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | Unresolved — no canonical attribution shown | $47.22 | 25.5% | 3 | 2025 |
| Otsuka America Pharmaceutical, Inc. | Unresolved — no canonical attribution shown | $36.11 | 19.5% | 2 | 2025 |
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $35.50 | 19.1% | 2 | 2025 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | Unresolved — no canonical attribution shown | $30.70 | 16.6% | 2 | 2025 |
| Dexcom, Inc. | Unresolved — no canonical attribution shown | $19.66 | 10.6% | 1 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $16.25 | 8.8% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $185.44 | 11 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| AUSTEDO XR Normalized: austedo xr |
Drug | Teva Pharmaceuticals USA, Inc. | $47.22 | 3 | 2025 |
Source payment records
|
|||||
| REXULTI Normalized: rexulti |
Drug | Otsuka America Pharmaceutical, Inc. | $36.11 | 2 | 2025 |
Source payment records
|
|||||
| Ozempic Normalized: ozempic |
Drug | Novo Nordisk Inc | $35.50 | 2 | 2025 |
Source payment records
|
|||||
| CAPLYTA Normalized: caplyta |
Drug | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $30.70 | 2 | 2025 |
Source payment records
|
|||||
| Dexcom G6 Transmitter Normalized: dexcom g6 transmitter |
Medical Supply | Dexcom, Inc. | $19.66 | 1 | 2025 |
Source payment records
|
|||||
| Cologuard Collection Kit Normalized: cologuard collection kit |
Device | Exact Sciences Corporation | $16.25 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| AUSTEDO XR austedo xr |
2025 | Austedo Xr | 2024 | 15 Beneficiary count suppressed |
exact normalized | Medicare Part D |
| Ozempic ozempic |
2025 | Ozempic | 2024 | 51 | exact normalized | Medicare Part D |
| REXULTI rexulti |
2025 | Rexulti | 2024 | 31 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
51 | 11 |
| Otsuka America Pharmaceutical, Inc. Exact reporting entity; no affiliate inference |
2025 | ABILIFY MAINTENA open payments reported associated product |
CMS Open Payments — General Payments 27924 supporting records · 10497 recipient NPIs · example record 1227267721 |
Abilify Maintena · 2024 Exact normalized brand match · 1 Part D row |
11 | suppressed by CMS |
| Otsuka America Pharmaceutical, Inc. Exact reporting entity; no affiliate inference |
2025 | REXULTI open payments reported associated product |
CMS Open Payments — General Payments 160756 supporting records · 46288 recipient NPIs · example record 1227267708 |
Rexulti · 2024 Exact normalized brand match · 1 Part D row |
31 | suppressed by CMS |
| Teva Pharmaceuticals USA, Inc. Exact reporting entity; no affiliate inference |
2025 | AUSTEDO XR open payments reported associated product |
CMS Open Payments — General Payments 86263 supporting records · 23643 recipient NPIs · example record 1247244228 |
Austedo Xr · 2024 Exact normalized brand match · 1 Part D row |
15 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 761 | 75 |
| Atorvastatin Calcium | Atorvastatin Calcium | 745 | 146 |
| Pantoprazole Sodium | Pantoprazole Sodium | 620 | 142 |
| Gabapentin | Gabapentin | 608 | 104 |
| Amlodipine Besylate | Amlodipine Besylate | 545 | 118 |
| Famotidine | Famotidine | 504 | 77 |
| Furosemide | Furosemide | 418 | 72 |
| Potassium Chloride | Potassium Chloride | 401 | 87 |
| Eliquis | Apixaban | 373 | 42 |
| Fluticasone Propionate | Fluticasone Propionate | 352 | 106 |
| Losartan Potassium | Losartan Potassium | 349 | 72 |
| Tamsulosin Hcl | Tamsulosin Hcl | 342 | 69 |
| Mirtazapine | Mirtazapine | 336 | 61 |
| Carvedilol | Carvedilol | 304 | 68 |
| Donepezil Hcl | Donepezil Hcl | 292 | 45 |
| Latanoprost | Latanoprost | 288 | 50 |
| Simvastatin | Simvastatin | 281 | 58 |
| Metoprolol Succinate | Metoprolol Succinate | 264 | 62 |
| Montelukast Sodium | Montelukast Sodium | 242 | 62 |
| Clopidogrel | Clopidogrel Bisulfate | 234 | 50 |
| Metformin Hcl | Metformin Hcl | 214 | 56 |
| Omeprazole | Omeprazole | 209 | 52 |
| Lisinopril | Lisinopril | 202 | 42 |
| Buspirone Hcl | Buspirone Hcl | 201 | 30 |
| Quetiapine Fumarate | Quetiapine Fumarate | 199 | 24 |
| Trazodone Hcl | Trazodone Hcl | 197 | 36 |
| Metoprolol Tartrate | Metoprolol Tartrate | 194 | 32 |
| Diclofenac Sodium | Diclofenac Sodium | 192 | 83 |
| Alprazolam | Alprazolam | 191 | 34 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 190 | 47 |
| Divalproex Sodium | Divalproex Sodium | 184 | 20 |
| Pregabalin | Pregabalin | 176 | 43 |
| Hydrochlorothiazide | Hydrochlorothiazide | 173 | 43 |
| Allopurinol | Allopurinol | 171 | 30 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 169 | 52 |
| Hydralazine Hcl | Hydralazine Hcl | 161 | 34 |
| Memantine Hcl | Memantine Hcl | 155 | 18 |
| Tramadol Hcl | Tramadol Hcl | 155 | 28 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 148 | 54 |
| Sertraline Hcl | Sertraline Hcl | 147 | 25 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 145 | 36 |
| Colchicine | Colchicine | 142 | 35 |
| Escitalopram Oxalate | Escitalopram Oxalate | 137 | 22 |
| Oxycodone Hcl | Oxycodone Hcl | 131 | 33 |
| Citalopram Hbr | Citalopram Hydrobromide | 125 | 18 |
| Levetiracetam | Levetiracetam | 121 | 17 |
| Januvia | Sitagliptin Phosphate | 117 | 11 |
| Lorazepam | Lorazepam | 116 | 27 |
| Pravastatin Sodium | Pravastatin Sodium | 115 | 23 |
| Farxiga | Dapagliflozin Propanediol | 112 | 21 |
| Metformin Hcl Er | Metformin Hcl | 111 | 36 |
| Lubiprostone | Lubiprostone | 109 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 106 | 12 |
| Meloxicam | Meloxicam | 106 | 27 |
| Clonazepam | Clonazepam | 105 | 23 |
| Duloxetine Hcl | Duloxetine Hcl | 98 | 24 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 90 | 21 |
| Prednisone | Prednisone | 90 | 18 |
| Clonidine Hcl | Clonidine Hcl | 88 | 23 |
| Lamotrigine | Lamotrigine | 87 | 11 |
| Risperidone | Risperidone | 82 | 11 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 81 | 22 |
| Linzess | Linaclotide | 80 | 16 |
| Jardiance | Empagliflozin | 79 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 79 | 33 |
| Meclizine Hcl | Meclizine Hcl | 77 | 18 |
| Baclofen | Baclofen | 76 | suppressed |
| Xarelto | Rivaroxaban | 71 | 11 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 70 | 20 |
| Topiramate | Topiramate | 70 | 12 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 69 | 16 |
| Olanzapine | Olanzapine | 67 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 65 | 12 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 59 | 17 |
| Ezetimibe | Ezetimibe | 58 | 15 |
| Tizanidine Hcl | Tizanidine Hcl | 58 | 16 |
| Doxycycline Hyclate | Doxycycline Hyclate | 57 | 42 |
| Finasteride | Finasteride | 57 | 12 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 57 | 13 |
| Chlorthalidone | Chlorthalidone | 56 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 53 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 53 | 14 |
| Brimonidine Tartrate | Brimonidine Tartrate | 52 | 11 |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 52 | suppressed |
| Valsartan | Valsartan | 52 | 14 |
| Ozempic | Semaglutide | 51 | 11 |
| Digoxin | Digoxin | 50 | 11 |
| Azithromycin | Azithromycin | 49 | 40 |
| Sucralfate | Sucralfate | 49 | 12 |
| Adacel Tdap | Diph,pertuss(Acell),tet Vac/Pf | 47 | 47 |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 47 | suppressed |
| Mupirocin | Mupirocin | 45 | 28 |
| Sulindac | Sulindac | 45 | 15 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 44 | suppressed |
| Ketoconazole | Ketoconazole | 44 | 18 |
| Enalapril Maleate | Enalapril Maleate | 43 | 11 |
| Fluconazole | Fluconazole | 43 | 30 |
| Spironolactone | Spironolactone | 43 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 42 | suppressed |
| Savella | Milnacipran Hcl | 42 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 41 | suppressed |
| Levemir | Insulin Detemir | 41 | suppressed |
| Ramipril | Ramipril | 41 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 41 | 17 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 40 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 40 | suppressed |
| Dutasteride | Dutasteride | 39 | suppressed |
| Famciclovir | Famciclovir | 38 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 38 | 34 |
| Haloperidol | Haloperidol | 37 | suppressed |
| Ranolazine Er | Ranolazine | 37 | suppressed |
| Trulicity | Dulaglutide | 37 | suppressed |
| Isosorbide Mononitrate | Isosorbide Mononitrate | 36 | suppressed |
| Novolin R | Insulin Regular, Human | 36 | suppressed |
| Nystatin | Nystatin | 36 | 19 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 36 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 35 | 31 |
| Diltiazem Hcl | Diltiazem Hcl | 35 | suppressed |
| Glimepiride | Glimepiride | 35 | 11 |
| Methocarbamol | Methocarbamol | 35 | 11 |
| Zolpidem Tartrate | Zolpidem Tartrate | 35 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 34 | 22 |
| Metoclopramide Hcl | Metoclopramide Hcl | 34 | suppressed |
| Novolog | Insulin Aspart | 34 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 33 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 32 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 32 | suppressed |
| Calcitonin-Salmon | Calcitonin,salmon,synthetic | 31 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 31 | suppressed |
| Methotrexate | Methotrexate Sodium | 31 | suppressed |
| Rexulti | Brexpiprazole | 31 | suppressed |
| Safetyglide Insulin Syringe | Syringe,needle,insuln,sf 0.5ml | 31 | suppressed |
| Felodipine Er | Felodipine | 30 | suppressed |
| Ibuprofen | Ibuprofen | 30 | suppressed |
| Lactulose | Lactulose | 30 | 13 |
| Naproxen | Naproxen | 30 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 30 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 29 | 13 |
| Warfarin Sodium | Warfarin Sodium | 29 | suppressed |
| Bumetanide | Bumetanide | 28 | 12 |
| Cephalexin | Cephalexin | 28 | 26 |
| Lithium Carbonate | Lithium Carbonate | 28 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 28 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 28 | suppressed |
| Amlodipine-Olmesartan | Amlodipine Bes/Olmesartan Med | 27 | suppressed |
| Celecoxib | Celecoxib | 27 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 27 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 27 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 26 | suppressed |
| Nystop | Nystatin | 26 | 15 |
| Fluoxetine Hcl | Fluoxetine Hcl | 25 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 24 | 20 |
| Rivastigmine | Rivastigmine | 24 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 23 | suppressed |
| Clonidine | Clonidine | 23 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 23 | suppressed |
| Atenolol | Atenolol | 22 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 22 | suppressed |
| Guanfacine Hcl | Guanfacine Hcl | 22 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 22 | suppressed |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 22 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 22 | suppressed |
| Nifedipine Er | Nifedipine | 22 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 22 | suppressed |
| Norethindrone | Norethindrone | 21 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 21 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 21 | suppressed |
| Timolol Maleate | Timolol Maleate | 21 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 21 | suppressed |
| Entresto | Sacubitril/Valsartan | 20 | suppressed |
| Estradiol | Estradiol | 20 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 20 | suppressed |
| Methimazole | Methimazole | 20 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 20 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 19 | suppressed |
| Bupropion Xl | Bupropion Hcl | 19 | suppressed |
| Cilostazol | Cilostazol | 19 | suppressed |
| Creon | Lipase/Protease/Amylase | 19 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 19 | suppressed |
| Glipizide | Glipizide | 19 | suppressed |
| Insulin Aspart | Insulin Aspart | 19 | suppressed |
| Invega Sustenna | Paliperidone Palmitate | 19 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 18 | suppressed |
| Fenofibrate | Fenofibrate | 18 | suppressed |
| Gemtesa | Vibegron | 18 | suppressed |
| Lovastatin | Lovastatin | 18 | suppressed |
| Lumigan | Bimatoprost | 18 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 18 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 18 | 16 |
| Venlafaxine Hcl | Venlafaxine Hcl | 18 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 18 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 17 | suppressed |
| Brimonidine Tartrate-Timolol | Brimonidine Tartrate/Timolol | 17 | suppressed |
| Combigan | Brimonidine Tartrate/Timolol | 17 | suppressed |
| Humulin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 17 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 17 | suppressed |
| Methylprednisolone | Methylprednisolone | 17 | suppressed |
| Nitroglycerin | Nitroglycerin | 17 | 11 |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 17 | suppressed |
| Carbamazepine | Carbamazepine | 16 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 16 | suppressed |
| Cefdinir | Cefdinir | 16 | 16 |
| Humalog | Insulin Lispro | 16 | suppressed |
| Minocycline Hcl | Minocycline Hcl | 16 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 16 | 12 |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 16 | 13 |
| Sprycel | Dasatinib | 16 | suppressed |
| Travoprost | Travoprost | 16 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 15 | suppressed |
| Austedo Xr | Deutetrabenazine | 15 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 15 | suppressed |
| Butalb-Acetaminoph-Caff-Codein | Butalbit/Acetamin/Caff/Codeine | 15 | suppressed |
| Clotrimazole | Clotrimazole | 15 | suppressed |
| Fentanyl | Fentanyl | 15 | suppressed |
| Lacosamide | Lacosamide | 15 | suppressed |
| Levofloxacin | Levofloxacin | 15 | 11 |
| Restasis | Cyclosporine | 15 | suppressed |
| Trueplus Insulin Syringe | Syringe-Needle,insulin,0.5 Ml | 15 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 14 | 11 |
| Aripiprazole | Aripiprazole | 14 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 14 | suppressed |
| Lagevrio (Eua) | Molnupiravir | 14 | 14 |
| Lidocaine | Lidocaine | 14 | suppressed |
| Paricalcitol | Paricalcitol | 14 | suppressed |
| Potassium Citrate Er | Potassium Citrate | 14 | suppressed |
| Sevelamer Hcl | Sevelamer Hcl | 14 | suppressed |
| Acetazolamide | Acetazolamide | 13 | suppressed |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 13 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 13 | suppressed |
| Cefadroxil | Cefadroxil | 13 | 13 |
| Fenofibrate | Fenofibrate,micronized | 13 | suppressed |
| Invokana | Canagliflozin | 13 | suppressed |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 13 | 12 |
| Letrozole | Letrozole | 13 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 13 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 13 | suppressed |
| Testosterone | Testosterone | 13 | suppressed |
| Amoxicillin | Amoxicillin | 12 | 12 |
| Azelastine Hcl | Azelastine Hcl | 12 | suppressed |
| Carbidopa | Carbidopa | 12 | suppressed |
| Cartia Xt | Diltiazem Hcl | 12 | suppressed |
| Clozapine | Clozapine | 12 | suppressed |
| Estradiol (Once Weekly) | Estradiol | 12 | suppressed |
| Fenofibric Acid | Fenofibric Acid (Choline) | 12 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 12 | suppressed |
| Icosapent Ethyl | Icosapent Ethyl | 12 | suppressed |
| Indomethacin | Indomethacin | 12 | suppressed |
| Lamotrigine Er | Lamotrigine | 12 | suppressed |
| Loperamide | Loperamide Hcl | 12 | suppressed |
| Methylprednisolone Acetate | Methylprednisolone Acetate | 12 | suppressed |
| Metolazone | Metolazone | 12 | suppressed |
| Tramadol Hcl-Acetaminophen | Tramadol Hcl/Acetaminophen | 12 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 12 | suppressed |
| Abilify Maintena | Aripiprazole | 11 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 11 | suppressed |
| Comfort Ez Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 11 | suppressed |
| Erythromycin | Erythromycin Base | 11 | suppressed |
| Humulin R | Insulin Regular, Human | 11 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl | 11 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl/Pf | 11 | suppressed |
| Metformin Er Osmotic | Metformin Hcl | 11 | suppressed |
| Metronidazole | Metronidazole | 11 | suppressed |
| Monoject Insulin Syringe | Syringe-Needle,insulin,0.5 Ml | 11 | suppressed |
| Myrbetriq | Mirabegron | 11 | suppressed |
| Ondansetron Odt | Ondansetron | 11 | suppressed |
| Phenobarbital | Phenobarbital | 11 | suppressed |
| Repaglinide | Repaglinide | 11 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $185.44 · 11 records | Teva Pharmaceuticals USA, Inc. | AUSTEDO XR, CAPLYTA, Cologuard Collection Kit, Dexcom G6 Transmitter, Ozempic, REXULTI | 4 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Austedo Xr play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Novo Nordisk Inc?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error